GFACX
Price
$56.51
Change
-$2.32 (-3.94%)
Updated
Apr 10 closing price
Net Assets
271.59B
VAFNX
Price
$26.08
Change
-$1.17 (-4.29%)
Updated
Apr 10 closing price
Net Assets
14.41B
Ad is loading...

GFACX vs VAFNX

Header iconGFACX vs VAFNX Comparison
Open Charts GFACX vs VAFNXBanner chart's image
American Funds Growth Fund of Amer C
Price$56.51
Change-$2.32 (-3.94%)
VolumeN/A
Net Assets271.59B
Invesco American Franchise R5
Price$26.08
Change-$1.17 (-4.29%)
VolumeN/A
Net Assets14.41B
GFACX vs VAFNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GFACX vs. VAFNX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Hold and VAFNX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 272B vs. VAFNX (14.4B). GFACX (0.00) and VAFNX (0.00) have matching dividends . GFACX was incepted earlier than VAFNX: GFACX (24 years) vs VAFNX (14 years). GFACX (1.36) is less costly to investors than VAFNX (0.70). VAFNX is a more actively managed with annual turnover of: 51.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than VAFNX: GFACX (250) vs VAFNX (1000000). VAFNX annual gain was more profitable for investors over the last year : -0.62 vs. GFACX (-3.95). GFACX return over 5 years is better than : 40.74 vs. VAFNX (33.12).
GFACXVAFNXGFACX / VAFNX
Total Expense Ratio1.360.70194%
Annual Report Gross Expense Ratio1.360.70194%
Fund Existence24 years14 years-
Gain YTD-7.732-13.16159%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets272B14.4B1,889%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.95-0.62637%
Returns for 3 years4.3519.5722%
Returns for 5 years40.7433.12123%
Returns for 10 years38.8254.3971%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DGLY0.03N/A
+15.27%
Digital Ally
BDSX0.570.02
+4.51%
Biodesix
TAP59.951.44
+2.46%
Molson Coors Beverage Company
GYRE7.29-0.51
-6.54%
Gyre Therapeutics
GDRX4.32-0.37
-7.89%
GoodRx Holdings